FDA-Inspected Site

Element Materials Technology Ann Arbor, LLC

5 FDA inspections are on record for Element Materials Technology Ann Arbor, LLC in Ann Arbor, United States.

Clean· No action indicated

Ann Arbor, United States · Last updated July 10, 2026

Overview

  • 5 FDA inspections are on record.
  • 2 inspections produced a Form 483.
  • The most recent recorded inspection date is 2026-02-23.

At a glance

Inspections

5

Form 483s

2

EIRs

0

Last outcome

Clean

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
18 Feb 2026 – 23 Feb 2026Human DrugsClean
5 Sep 2022 – 9 Sep 2022Human Drugs483View 483 →
24 Oct 2018 – 30 Oct 2018Human DrugsClean
19 Mar 2018 – 22 Mar 2018Human Drugs483View 483 →
22 Jun 2016 – 28 Jun 2016Human DrugsClean

Observations on record

Form 483 observations cited at this site, most recent first.

9 Sep 2022
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Alan M Barker, Joseph A Piechocki

9 Sep 2022
21 CFR 211.68(b)

Computer control of master formula records

Cited by Alan M Barker, Joseph A Piechocki

22 Mar 2018
21 CFR 211.22(b)

Adequate lab facilities not available

Cited by Emily J Orban

22 Mar 2018
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Emily J Orban

22 Mar 2018
21 CFR 211.22(b)

Adequate lab facilities not available

Cited by Emily J Orban

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.22(d)Cited across public-safe Form 483 observations3x
21 CFR 211.22(b)Cited across public-safe Form 483 observations2x
21 CFR 211.68(b)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Element Materials Technology Ann Arbor, LLC's 2 Form 483s

Source PDFs and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat